Literature DB >> 10449130

Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain.

K Tajima1, T Kawanami, R Nagai, S Horiuchi, T Kato.   

Abstract

We investigated the role of ceruloplasmin in the antioxidative process in the brain in a patient with hereditary ceruloplasmin deficiency (HCD). Immunohistochemistry revealed an accumulation of Nepsilon-(carboxymethyl) lysine (CML) in basal ganglia of the HCD brain. In vitro study disclosed that ceruloplasmin inhibited CML formation from glycated proteins through the reaction of Fe2+ with H2O2 by Fenton reaction. These data suggest that ceruloplasmin plays an important role in the protection of neurons against oxidative stress associated with iron metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449130     DOI: 10.1212/wnl.53.3.619

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.

Authors:  Rubén Martínez-Hernández; Sergio Montes; Jesus Higuera-Calleja; Petra Yescas; Marie-Catherine Boll; Araceli Diaz-Ruiz; Camilo Rios
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

2.  Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.

Authors:  Satoshi Kono; Hitoshi Suzuki; Toshiaki Oda; Hiroaki Miyajima; Yoshitomo Takahashi; Kentaro Shirakawa; Kuniko Ishikawa; Masatoshi Kitagawa
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy.

Authors:  Heather D VanGuilder; Georgina V Bixler; Lydia Kutzler; Robert M Brucklacher; Sarah K Bronson; Scot R Kimball; Willard M Freeman
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

Review 4.  Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Authors:  Daniela Berg; Helmine Hochstrasser; Katherine J Schweitzer; Olaf Riess
Journal:  Neurotox Res       Date:  2006-01       Impact factor: 3.978

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.